CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $240,627
- in 2 filings, $39K under 10b5-1 plans
Net −$240,627. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +16,377 | 16,377 | ||
| 2025-06-16 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-04-03 | Thompson Peter A. Director | Purchase | +372,578 | $20.13 | $7.5M | 14,809,075 |
| 2025-04-03 | Thompson Peter A. Director | Purchase | +124,193 | $20.13 | $2.5M | 443,792 |
| 2024-06-10 | Thompson Peter A. Director | Grant or award · Stock Options (Right to buy) | +20,594 | 20,594 | ||
| 2024-01-23 | Thompson Peter A. Director | Purchase | +454,545 | $11.00 | $5.0M | 14,436,497 |
| 2023-06-12 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +22,123 | 22,123 | ||
| 2022-09-16 | Thompson Peter A. Director | Purchase | +484,496 | $10.32 | $5.0M | 13,981,952 |
| 2022-06-24 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +42,087 | 42,087 | ||
| 2022-05-18 | Thompson Peter A. Director | Purchase | +138,000 | $7.21 | $995K | 13,497,456 |
| 2021-03-30 | Thompson Peter A. Director | Conversion | +12,730,036 | 13,046,956 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion | +272,724 | 272,724 | ||
| 2021-03-30 | Thompson Peter A. Director | Purchase | +46,875 | $16.00 | $750K | 319,599 |
| 2021-03-30 | Thompson Peter A. Director | Purchase | +312,500 | $16.00 | $5.0M | 13,359,456 |
| 2021-03-30 | Thompson Peter A. Director | Conversion · Series A Preferred Stock | −8,187,100 | 0 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion · Series B-1 Preferred Stock | −1,572,960 | 0 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion · Series B-2 Preferred Stock | −1,301,626 | 0 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion · Series C Preferred Stock | −1,668,350 | 0 | ||
| 2021-03-30 | Thompson Peter A. Director | Conversion · Series C Preferred Stock | −272,724 | 0 |
Page 1 of 1 · 19 trades